Caribou Biosciences’ multiple myeloma treatment was granted orphan status by the FDA, according to a post to the agency’s website.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CRBU:
- Snowflake upgraded, Lucid downgraded: Wall Street’s top analyst calls
- Cantor Fitzgerald cautious on Caribou Biosciences, starts a Neutral
- Caribou Biosciences initiated with a Neutral at Cantor Fitzgerald
- Caribou Biosciences appoints Sundar Jagannath, MD to Scientific Advisory Board
- Caribou Biosciences reports Q3 EPS (12c), consensus (42c)
